2m 2m 2m 2m 2m 2m 2m
CELULARITY-A (CELU)
NASDAQ
$1.24+$0.19 (+18.19%)
Price as of Oct 23, 2026 4:02 AM EDT- $33.1MMarket Cap
- -47.24%1-Year Change
- BiotechnologyIndustry
CELULARITY-A (CELU)
$1.24+$0.19 (+18.19%)
CELU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.05 | ||
Change | +$0.03 (+2.94%) | ||
Open | $1.07 | ||
High | $1.08 | ||
Low | $1.01 | ||
Previous Close | $1.02 | ||
Volume | 144,726 | ||
30-Day Average Volume | 128,478 | ||
1-Week Change | -21.05% | ||
1-Month Change | -11.02% | ||
1-Year Change | -47.24% | ||
3-Year Change | -55.53% | ||
5-Year Change | -98.48% | ||
Fundamentals | |||
Shares Outstanding | 32.4M | ||
Total Assets | $96.2M | ||
Market Cap | $33.1M | ||
Enterprise Value | $35.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | $546,000.00 | ||
Free Cash Flow | -$1.1M | ||
EBIT | $546,000.00 | ||
EBITDA | $2.1M | ||
Net Working Capital | -$53.3M | ||
EPS | $0.02 | ||
Enterprise Value/EBITDA | 17 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 78 | ||
P/E | 51 | ||
PEG | N/A | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 02/29/2024 | ||
Earnings & Revenue